Literature DB >> 7575459

Heparin proteoglycans synthesized by mouse mastocytoma contain chondroitin sulphate.

K Lidholt1, I Eriksson, L Kjellén.   

Abstract

Proteoglycans (PGs), biosynthetically labelled with [35S]sulphate, were isolated from mouse mastocytoma tissue. Chromatography on antithrombin (AT)-Sepharose resulted in the separation of the 35S-labelled PGs into three fractions: PGs with no affinity for the gel (NA-PGs), PGs with low affinity (LA-PGs), and PGs with high affinity (HA-PGs) for antithrombin. Whereas NA-PGs contained almost exclusively chondroitin sulphate (CS), the AT-binding PGs contained 80-85% heparin and 15-20% CS. [35S]CS-containing macromolecules obtained from the HA-PG fraction after removal of the heparin polysaccharide chains were rechromatographed on AT-Sepharose. A majority of these 35S-labelled macromolecules no longer showed affinity for AT. These experiments indicate that the [35S]CS recovered in the AT-binding PGs is present in hybrid PGs. Polysaccharide chain-length determination demonstrated that the heparin chains were somewhat larger (M(r) approximately 30,000) than the CS chains in the NA-PGs (M(r) approximately 25,000). CS chains in the hybrid PGs were slightly smaller (M(r) approximately 20,000). Characterization of the sulphated CS disaccharides from NA- and HA-PGs showed that they contained similar amounts (20%) of disulphated disaccharides of [GlcA-GalNAc(4,6-di-OSO3)] type. The monosulphated CS-disaccharides were O-sulphated at C-4 of the galactosamine units. Analysis by gel chromatography of the [35S]CS components isolated from HA-PGs after heparinase treatment showed that a major portion of these contained one CS chain only. Calculations of the number of CS and heparin chains in AT-binding PGs, based on polysaccharide composition and polysaccharide chain length, indicate that all heparin-containing PGs are hybrids.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575459      PMCID: PMC1136143          DOI: 10.1042/bj3110233

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

Review 1.  Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.

Authors:  M Bernfield; R Kokenyesi; M Kato; M T Hinkes; J Spring; R L Gallo; E J Lose
Journal:  Annu Rev Cell Biol       Date:  1992

2.  Transplantable mastocytoma in the mouse containing histamine, heparin, 5-hydroxytryptamine.

Authors:  J FURTH; P HAGEN; E I HIRSCH
Journal:  Proc Soc Exp Biol Med       Date:  1957 Aug-Sep

3.  Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.

Authors:  M Höök; I Björk; J Hopwood; U Lindahl
Journal:  FEBS Lett       Date:  1976-07-01       Impact factor: 4.124

4.  Formation of anhydrosugars in the chemical depolymerization of heparin.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

5.  A proteoglycan form of heparin and its degradation to single-chain molecules.

Authors:  H C Robinson; A A Horner; M Höök; S Ogren; U Lindahl
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

6.  Phosphorylation of chondroitin sulfate in proteoglycans from the swarm rat chondrosarcoma.

Authors:  T R Oegema; E L Kraft; G W Jourdian; T R Van Valen
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

7.  Analysis of polysulfated chondroitin disaccharides by high-performance liquid chromatography.

Authors:  D C Seldin; N Seno; K F Austen; R L Stevens
Journal:  Anal Biochem       Date:  1984-08-15       Impact factor: 3.365

8.  Amino acid determinants that drive heparan sulfate assembly in a proteoglycan.

Authors:  L Zhang; J D Esko
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

Review 9.  Integral membrane heparan sulfate proteoglycans.

Authors:  G David
Journal:  FASEB J       Date:  1993-08       Impact factor: 5.191

10.  Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.

Authors:  U Lindahl; G Bäckström; L Thunberg; I G Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more
  5 in total

Review 1.  Intracellular proteoglycans.

Authors:  Svein Olav Kolset; Kristian Prydz; Gunnar Pejler
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

2.  Assessment of glycosaminoglycan-protein linkage tetrasaccharides as acceptors for GalNAc- and GlcNAc-transferases from mouse mastocytoma.

Authors:  K Lidholt; M Fjelstad; U Lindahl; F Goto; T Ogawa; H Kitagawa; K Sugahara
Journal:  Glycoconj J       Date:  1997-09       Impact factor: 2.916

3.  Bioengineering murine mastocytoma cells to produce anticoagulant heparin.

Authors:  Leyla Gasimli; Charles A Glass; Payel Datta; Bo Yang; Guoyun Li; Trent R Gemmill; Jong Youn Baik; Susan T Sharfstein; Jeffrey D Esko; Robert J Linhardt
Journal:  Glycobiology       Date:  2013-12-09       Impact factor: 4.313

4.  Heparan sulfate 6-O-sulfotransferase isoform-dependent regulatory effects of heparin on the activities of various proteases in mast cells and the biosynthesis of 6-O-sulfated heparin.

Authors:  Md Ferdous Anower-E-Khuda; Hiroko Habuchi; Naoko Nagai; Osami Habuchi; Takashi Yokochi; Koji Kimata
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

Review 5.  Serglycin: at the crossroad of inflammation and malignancy.

Authors:  Angeliki Korpetinou; Spyros S Skandalis; Vassiliki T Labropoulou; Gianna Smirlaki; Argyrios Noulas; Nikos K Karamanos; Achilleas D Theocharis
Journal:  Front Oncol       Date:  2014-01-13       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.